Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease
- PMID: 31783225
- DOI: 10.1016/j.cbpa.2019.10.006
Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease
Abstract
Glycosphingolipids are important building blocks of the outer leaflet of the cell membrane. They are continuously recycled, involving fragmentation inside lysosomes by glycosidases. Inherited defects in degradation cause lysosomal glycosphingolipid storage disorders. The relatively common glycosphingolipidosis Gaucher disease is highlighted here to discuss new insights in the molecular basis and pathophysiology of glycosphingolipidoses reached by fundamental research increasingly using chemical biology tools. We discuss improvements in the detection of glycosphingolipid metabolites by mass spectrometry and review new developments in laboratory diagnosis and disease monitoring as well as therapeutic interventions.
Keywords: Gaucher disease; Glucocerebrosidase; Glucosylsphingosine; Glycosphingolipids; Lysosome.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses.Biochim Biophys Acta. 2014 May;1841(5):811-25. doi: 10.1016/j.bbalip.2013.11.004. Epub 2013 Nov 13. Biochim Biophys Acta. 2014. PMID: 24239767 Review.
-
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases.FEBS Lett. 2016 Mar;590(6):716-25. doi: 10.1002/1873-3468.12104. Epub 2016 Mar 3. FEBS Lett. 2016. PMID: 26898341
-
Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention.Philos Trans R Soc Lond B Biol Sci. 2003 May 29;358(1433):905-14. doi: 10.1098/rstb.2003.1273. Philos Trans R Soc Lond B Biol Sci. 2003. PMID: 12803924 Free PMC article. Review.
-
Cultured Macrophage Models for the Investigation of Lysosomal Glucocerebrosidase and Gaucher Disease.Int J Mol Sci. 2025 Mar 18;26(6):2726. doi: 10.3390/ijms26062726. Int J Mol Sci. 2025. PMID: 40141367 Free PMC article.
-
Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease.Neurobiol Dis. 2016 Jul;91:143-54. doi: 10.1016/j.nbd.2016.03.011. Epub 2016 Mar 11. Neurobiol Dis. 2016. PMID: 26976737
Cited by
-
Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review.Int J Mol Sci. 2020 Sep 28;21(19):7159. doi: 10.3390/ijms21197159. Int J Mol Sci. 2020. PMID: 32998334 Free PMC article.
-
Deciphering metabolic shifts in Gaucher disease type 1: a multi-omics study.J Mol Med (Berl). 2025 Feb;103(2):187-203. doi: 10.1007/s00109-024-02512-x. Epub 2024 Dec 30. J Mol Med (Berl). 2025. PMID: 39738845
-
Gaucher disease: an update.Med Pharm Rep. 2021 Aug;94(Suppl No 1):S54-S56. doi: 10.15386/mpr-2231. Epub 2021 Aug 10. Med Pharm Rep. 2021. PMID: 34527912 Free PMC article.
-
Screening for Gaucher Disease Using Dried Blood Spot Tests: A Japanese Multicenter, Cross-sectional Survey.Intern Med. 2021;60(5):699-707. doi: 10.2169/internalmedicine.5064-20. Epub 2021 Mar 1. Intern Med. 2021. PMID: 33642560 Free PMC article.
-
Marine Biocompounds for Neuroprotection-A Review.Mar Drugs. 2020 May 31;18(6):290. doi: 10.3390/md18060290. Mar Drugs. 2020. PMID: 32486409 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical